OCNT-980 A Phase 1 small-molecule corrector designed to restore rhodopsin folding and trafficking across mutations that cause autosomal-dominant retinitis pigmentosa.
Visit productCosigns Received
Be the first Cosign
Put your name behind OCNT-980.
Add it to your Products I use list and share why you use it.